Hepatocellular carcinoma (HCC) with highly aggressive characteristics is usually actively proliferated and easily relapse, thereby requiring adjuvant therapies before surgery, like preoperative TACE, to improve the patients’ prognosis. Ki-67 labeling index (LI) was reported to be highly correlated with aggressive propensity of HCC, and thus could affect the treatment response of the tumor and prognosis directly. Although most of HCC presented hypointensity on hepatobiliary phase (HBP), the absolute signal intensity and relative contrast enhancement ratio are not the same. In this study, we prospectively investigate the usefulness of HBP quantitative parameters for preoperative prediction of aggressiveness in HCC patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords